AgingResearch.News
Preprints.org

Real-World Insulin Deintensification and Discontinuation with GLP-1 Incretin Therapies Versus SGLT2 Inhibitors in Type 2 Diabetes

By Robert Matson, A. J. Venkatakrishnan, Christopher J. Gregg, Karthik Murugadoss, Venky Soundararajan
Preprint: cohort study of 1,029 peopleInterventions

24 months

Paper

The paper

Robert Matson, A. J. Venkatakrishnan, Christopher J. Gregg, Karthik Murugadoss, Venky Soundararajan

Preprints.org, 31 Jul 2026, Preprint, not peer-reviewed

doi.org/10.20944/preprints202607.2282.v1

More on GLP-1 and incretin signalling